Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Boric Acid, Calcium, Magnesium
Norbrook Laboratories Limited
amended
Boric Acid, Calcium, Magnesium
Solution for injection
POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person
Cattle
Mineral
Authorized
1994-07-05
Revised: July 2010 ATCVet code amended 1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Calciject 40 CM Solution For Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Contains Calcium Borogluconate 40% w/v Magnesium Hypophosphite Hexahydrate 5% w/v Each 400ml contains : 11.9g calcium (provided by calcium gluconate and calcium borogluconate) 1.85g magnesium (provided by magnesium hypophosphite). Also contains 6.84% w/v boric acid. EXCIPIENTS: For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for Injection A clear pale yellow solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Indicated in the treatment of hypocalcaemia in cattle where increased blood magnesium levels are required. 4.3 CONTRAINDICATIONS None 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None Revised: July 2010 ATCVet code amended 2 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals The solution should be warmed to body temperature before administration. Intravenous injections should be given slowly in order to avoid possible neuromuscular dysfunction and cardiac insufficiency. Normal aseptic precautions should be observed. Sites of subcutaneous administration should be massaged gently. ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals Care should be taken to avoid accidental self-injection: may cause irritation at site of injection. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Occasional temporary swelling may occur at sites of subcutaneous administration. 4.7 USE DURING PREGNANCY, LACTATION OR LAY Safe for use during pregnancy and lactation 4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION None 4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE Administer by subcutaneous or slow intravenous injection Cattle:200 to 400 ml 4.10 OVERDOSE (SYMPTOMS, EMERGENCY PROCEDURES, ANTIDOTES), IF NECESSAR Read the complete document